FOMX News and Press, Foamix Pharmaceuticals Ltd. From 11/11/19

Shares of Foamix Pharmaceuticals (NASDAQ: FOMX) stock crashed in early trading Monday after the Israeli dermatological treatment company announced an agreement to acquire the competing, revenue-less pharmaceutical products business Menlo Therapeutics (NASDAQ: MNLO) in an all-stock tran...

Lipocine (NASDAQ: LPCN )  -77%  after FDA rejects second Tlando application. More news on: Lipocine Inc., NextCure, Inc., Foamix Pharmaceuticals Ltd., Stocks on the move, Read more ...

Foamix Pharmaceuticals (NASDAQ: FOMX ) and Menlo Therapeutics (NASDAQ: MNLO ) have signed a definitive merger agreement to create a combined biopharmaceutical company focused on the commercialization and development of therapeutics to serve patients in the dermatology space. More news on...

Foamix Pharmaceuticals (NASDAQ: FOMX ): Q3 GAAP EPS of -$0.41  beats by $0.05 . Cash and cash equivalents of $40.53M Press Release More news on: Foamix Pharmaceuticals Ltd., Earnings news and commentary, Healthcare stocks news,

REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address...

Combination establishes a dermatology-focused company with a broad portfolio of an approved product and late-stage dermatology assets Menlo’s serlopitant for pruritus associated with prurigo nodularis (“PN”) complements Foamix’s existing portfolio and addresses...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 130 weeks of public selections as part of this ongoing live forward-testing. In...

REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, announced today that the U.S. Patent and Trademark Office has issued U.S. Pat...

REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (Foamix or the Company), a specialty pharmaceutical company, announced today the peer review publication of the long term open label safety portions of studies FX2014-04 ...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than five years. This subset of the different portfolios I regularly analyze has now reached 129 weeks of public selections as part of this ongoing live forward-testing. ...